Step-down-Therapie als Regime der ersten Wahl - Bei Refluxkrankheit Läsionen und Symptome betrachten

Literatur

• 01 Bardhan K . Achim A . Riddermann T . et al . Achieving complete remission in patients with erosive gastroesophageal reflux disease (GERD): pantoprazole is comparable with esomeprazole. 13th United European Gastroenterology Week, Poster Session MON-G-106.  Gut. 2005;  54 (suppl 7) A106
• 02 Dupas J-L . Houcke P . Samoyeau R . for the French Collaborative Pantoprazole Study Group. Pantoprazole versus lansoprazole in French patients with reflux esophagitis.  Gastroenterol Clin Biol. 2001;  25 245-250
• 03 Gallo S . Dibidox M . Moguel A . et al . Clinical superiority of 40 mg pantoprazole (panto) compared to 2 x 150 mg ranitidine (rani) in the healing of reflux esophagitis (GERD II/III).  Gastroenterol . 1997;  112 (4) A123 (suppl)
• 04 Gillessen A . Beil W . Modlin IM . et al . 40 mg pantoprazole and 40 mg esomeprazole are equivalent in the healing of esophageal lesions and relief from gastroesophageal reflux disease-related symptoms.  J Clin Gastroenterol . 2004;  38 332-340
• 05 Goh KL . Wu C-YJ . Benamouzig M . et al . Pantoprazole 20 mg is as effective as esomeprazole 20 mg regarding remission rates in patients with healed GERD.  Gut . 2005;  54 (suppl 7) A108
• 06 Kaspari S . Kupcinskas L . Fischer R . et al . On-Demand-Therapie mit Pantoprazol 20 mg ist eine effektive und ökonomische Langzeitbehandlung in der Refluxkrankheit.  Z Gastro . 2004;  42 (6) 1231-1232, A73
• 07 van Renburg CJ . Honiball PJ . Grundling HD . et al . Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis.   Aliment Pharmacol Ther. 1996;  10 (3) 397-407
• 08 van Renburg CJ . Bardhan KD . Tulassay Z . et al . Pantoprazole 40 mg is comparable to esomeprazole 40 mg for first and sustained symptom relief in patients with erosive gastroesophageal reflux disease (GERD).  Gut . 2005;  54 (suppl 7) A108